Aging
Our work in Aging
-
Race Inequity in School Attendance Across the Jim Crow South and Its Implications for Black–White Disparities in Trajectories of Cognitive Function Among Older Adults
The study highlights the importance of using a more refined measure of schooling for understanding the education–cognitive health relationship.
Categorized in -
New USC Study Finds People of Color Live More Years with Dementia Diagnosis Than Non-Hispanic Whites
These findings further reinforce the need for targeted support and resources for families and patients living with Alzheimer’s and other dementias.
-
Aduhelm Decision Shows Medicare is Making a Mistake in the Fight Against Alzheimer’s
The medical need is too great that the FDA should not limit targeted therapies and diagnostics.
Categorized in -
Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care
In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.
Categorized in -
Substance Use Disorders Among Older Populations: What Role Do Race and Ethnicity Play in Treatment and Completion?
Researchers provide historical investigation of admissions and discharges for treatment episodes over the past two decades across race, ethnicity, gender, and age.
Categorized in -
Pilot Funding Available for Researchers of Alzheimer’s, Aging
Pilot funding amounts range from $25,000 to up to $45,000. An informational session on the application process will be held over zoom on Thursday, December 9, 2021, at 10:00 a.m. pacific.
-
The Costs of Developing Treatments for Alzheimer’s Disease: A Retrospective Exploration
In over 26 years of research and development in Alzheimer’s disease, only six novel drugs have reached FDA approval.
Categorized in -
NAM Expert Briefing on Social Science Research Questions Raised By the Use of Biomarkers for Alzheimer’s Disease Diagnostics
On June 28 and 29, 2021, the National Academies of Sciences, Engineering, and Medicine convened an expert meeting that addressed behavioral and social science research questions raised by the use of biomarkers and other measures for pre-clinical AD/ADRD diagnosis
-
NAS Report Outlines Priorities for the Next Ten Years of Alzheimer’s Research
Julie Zissimopoulos participated on the committee tasked with developing the research agenda.
-
Advancing the Economics of Palliative Care: The Value to Individuals and Families, Organizations, and Society
A palliative care research agenda can help lay the foundation for building a strong evidence base to guide public policies meant to advance affordable, equitable, high-quality, patient-centered care.
Categorized in